These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3130193)
1. Interleukin-2-induced production of interferon-gamma by resting human T cells and large granular lymphocytes: requirement for accessory cell factors, including interleukin-1. Wilson AB; Harris JM; Coombs RR Cell Immunol; 1988 Apr; 113(1):130-42. PubMed ID: 3130193 [TBL] [Abstract][Full Text] [Related]
2. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes. Umetsu DT; Katzen D; Jabara HH; Geha RS J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491 [TBL] [Abstract][Full Text] [Related]
4. One-signal requirement for interferon-gamma production by human large granular lymphocytes. Young HA; Ortaldo JR J Immunol; 1987 Aug; 139(3):724-7. PubMed ID: 3110282 [TBL] [Abstract][Full Text] [Related]
5. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261 [TBL] [Abstract][Full Text] [Related]
6. In vitro assays to study role of T cell-derived factors on human B lymphocytes should take into consideration inhibiting effect of large granular lymphocyte subset (CD5-,CD16+) that can contaminate B cell preparations. Lobo PI; Wright AE J Immunol Methods; 1988 Dec; 115(2):239-46. PubMed ID: 3264313 [TBL] [Abstract][Full Text] [Related]
7. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. Geppert TD; Lipsky PE J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267 [TBL] [Abstract][Full Text] [Related]
8. High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors. Quiding M; Granström G; Nordström I; Ferrua B; Holmgren J; Czerkinsky C Clin Exp Immunol; 1993 Jan; 91(1):157-63. PubMed ID: 8093434 [TBL] [Abstract][Full Text] [Related]
9. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. Chan SH; Perussia B; Gupta JW; Kobayashi M; Pospísil M; Young HA; Wolf SF; Young D; Clark SC; Trinchieri G J Exp Med; 1991 Apr; 173(4):869-79. PubMed ID: 1672545 [TBL] [Abstract][Full Text] [Related]
10. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
11. Bacterial lipopolysaccharide-induced interferon-gamma production: roles of interleukin 1 and interleukin 2. Le J; Lin JX; Henriksen-DeStefano D; Vilcek J J Immunol; 1986 Jun; 136(12):4525-30. PubMed ID: 3086435 [TBL] [Abstract][Full Text] [Related]
12. Proliferation of human CD4+45R+ and CD4+45R- T helper cells is promoted by both IL-2 and IL-4 while interferon-gamma production is restricted to IL-2 activated CD4+45R- T cells. Dohlsten M; Hedlund G; Fischer H; Sjögren HO; Carlsson R Immunol Lett; 1989 Jan; 20(1):29-34. PubMed ID: 2523864 [TBL] [Abstract][Full Text] [Related]
13. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity. Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337 [TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. Blanchard DK; Djeu JY; Klein TW; Friedman H; Stewart WE J Immunol; 1986 Feb; 136(3):963-70. PubMed ID: 2867114 [TBL] [Abstract][Full Text] [Related]
15. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374 [TBL] [Abstract][Full Text] [Related]
16. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells. Kawakami K; Yamamoto Y; Kakimoto K; Onoue K J Immunol; 1989 Mar; 142(6):1818-25. PubMed ID: 2493498 [TBL] [Abstract][Full Text] [Related]
17. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. Cunningham AL; Nelson PA; Fathman CG; Merigan TC J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967 [TBL] [Abstract][Full Text] [Related]
18. Characterization of human interferon-gamma-producing leukocytes with monoclonal antileukocyte antibodies. Abb J; Abb H; Deinhardt F Med Microbiol Immunol; 1983; 171(4):215-23. PubMed ID: 6406805 [TBL] [Abstract][Full Text] [Related]
19. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells. Tilden AB; Itoh K; Balch CM J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627 [TBL] [Abstract][Full Text] [Related]
20. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]